Book a Meeting

BetterBet™ Anti-CD19 Recycling Antibody (CAT#: AES-0622-ZP48) Datasheet

Target
CD19
Description
This is a anti-CD19 recycling antibody provided by Creative Biolabs.
Applications
Enhanced mouse antigen eliminating
Technology
Antibody variable/constant engineering

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced CD19 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
CD19
Full Name
CD19 molecule
Alternative Names
CD19; CD19 molecule; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4
Description
This is a anti-CD19 recycling antibody provided by Creative Biolabs.

A recycling antibody combines two antibody engineering techniques: one is variable region engineering, which enables the antibody to bind to the antigen in the plasma and dissociate from the antigen in the endosome (after which the antigen undergoes lysosomal degradation), the other is constant region engineering to increase cellular uptake of antibody-antigen complexes into endosomes.

Related Products

Non-fucosylated Anti-Human CD19 (Denintuzumab) Therapeutic Antibody (CAT#: BioBet-105ZP)
ADCC-Enhanced Anti-Human CD19 (Tafasitamab) Antibody (CAT#: BioBet-CB-003LX)
ADCC-Enhanced Anti-Human CD19 (Loncastuximab) Antibody (CAT#: BioBet-CB-030LX)
Non-Fucosylated Anti-Human CD19 (4G7) Therapeutic Antibody (CAT#: BioBet-1693ZP)
Non-Fucosylated Anti-Human CD19 (R005-1) Therapeutic Antibody (CAT#: BioBet-1694ZP)
BetterBet™ Anti-CD19 Half-Life Extended Antibody (CAT#: AES-0622-ZP1032)
Highly Galactosylated Anti-CD19 (denintuzumab mafodotin) Antibody (CAT#: BioBet-GA-107ZP)
Non-Fucosylated Anti-Human CD19 (3649-aFuc) Therapeutic Antibody (CAT#: BioBet-1674ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.